SCHEMBL6771031

SCHEMBL6771031

C=CCC1(C(=O)O)c2ccccc2-c2cccc(Cl)c21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.42
THRB P10828 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PGR P06401 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
APEX1 P27695 1/20 0.36
CYP1A2 P05177 1/20 0.35
CXCR5 P32302 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
LMNA P02545 1/20 0.34
NPY1R P25929 1/20 0.34
NPY2R P49146 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 3/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
AKR1B1 P15121 1/20 0.33
APAF1 O14727 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864017 0.85 THRB (0.48) PDK2THRBTDP1PGRALDH1A1
Hydrochloric Acid SCHEMBL6771034 0.84 THRB (0.47) PDK2THRBTDP1PGRALDH1A1
SCHEMBL6771024 0.77 THRB (0.39) PDK2THRBTDP1PGRALDH1A1
SCHEMBL27859283 0.76 PGR (0.47) PDK2PGRALDH1A1HPGDAPEX1
SCHEMBL6777664 0.76 PDK2 (0.40) PDK2THRBTDP1APEX1CRHBP
SCHEMBL6649344 0.71 PDK2 (0.40) PDK2ALDH1A1L3MBTL1KMT2AMEN1
Butane SCHEMBL28645193 0.70 THRB (0.35) PDK2THRBTDP1PGRALDH1A1
SCHEMBL15691564 0.69 THRB (0.57) PDK2THRBTDP1ALDH1A1APEX1
SCHEMBL15691696 0.69 THRB (0.57) PDK2THRBTDP1ALDH1A1APEX1
SCHEMBL5864282 0.69 MAPT (0.39) PDK2ALDH1A1CYP1A2LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6821967-B2 AMINES SUCH AS 9-(4-(4-(BENZOTHIAZOL-2-YL)-PIPERAZIN-1-YL)-BUTYL)-9H-FLUORENE-9-CARBOXYLIC ACID (2,2,2-TRIFLUOROETHYL) AMIDE, USED AS MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN ANTAGONISTS, TO PREVENT ATHEROSCLEROSIS OR HYPERLIPEMIA BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-11-23 US disclosed
US-20030166637-A1 Substituted piperazine derivatives, the preparation thereofand their use as medicaments BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166637-A1 Substituted piperazine derivatives, the preparation thereofand their use as medicaments MTTP, CETP, CPT1A PDK2 2794/4885THRB 1383/4885TDP1 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.